1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Androgen Deprivation Therapy (ADT) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Medicine 1.2.3 Surgery 1.2.4 Other 1.3 Market by Application 1.3.1 Global Androgen Deprivation Therapy (ADT) Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Androgen Deprivation Therapy (ADT) Market Perspective (2016-2027) 2.2 Androgen Deprivation Therapy (ADT) Growth Trends by Regions 2.2.1 Androgen Deprivation Therapy (ADT) Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Androgen Deprivation Therapy (ADT) Historic Market Share by Regions (2016-2021) 2.2.3 Androgen Deprivation Therapy (ADT) Forecasted Market Size by Regions (2022-2027) 2.3 Androgen Deprivation Therapy (ADT) Industry Dynamic 2.3.1 Androgen Deprivation Therapy (ADT) Market Trends 2.3.2 Androgen Deprivation Therapy (ADT) Market Drivers 2.3.3 Androgen Deprivation Therapy (ADT) Market Challenges 2.3.4 Androgen Deprivation Therapy (ADT) Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Androgen Deprivation Therapy (ADT) Players by Revenue 3.1.1 Global Top Androgen Deprivation Therapy (ADT) Players by Revenue (2016-2021) 3.1.2 Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Players (2016-2021) 3.2 Global Androgen Deprivation Therapy (ADT) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Androgen Deprivation Therapy (ADT) Revenue 3.4 Global Androgen Deprivation Therapy (ADT) Market Concentration Ratio 3.4.1 Global Androgen Deprivation Therapy (ADT) Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Androgen Deprivation Therapy (ADT) Revenue in 2020 3.5 Androgen Deprivation Therapy (ADT) Key Players Head office and Area Served 3.6 Key Players Androgen Deprivation Therapy (ADT) Product Solution and Service 3.7 Date of Enter into Androgen Deprivation Therapy (ADT) Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Androgen Deprivation Therapy (ADT) Breakdown Data by Type 4.1 Global Androgen Deprivation Therapy (ADT) Historic Market Size by Type (2016-2021) 4.2 Global Androgen Deprivation Therapy (ADT) Forecasted Market Size by Type (2022-2027) 5 Androgen Deprivation Therapy (ADT) Breakdown Data by Application 5.1 Global Androgen Deprivation Therapy (ADT) Historic Market Size by Application (2016-2021) 5.2 Global Androgen Deprivation Therapy (ADT) Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Androgen Deprivation Therapy (ADT) Market Size (2016-2027) 6.2 North America Androgen Deprivation Therapy (ADT) Market Size by Type 6.2.1 North America Androgen Deprivation Therapy (ADT) Market Size by Type (2016-2021) 6.2.2 North America Androgen Deprivation Therapy (ADT) Market Size by Type (2022-2027) 6.2.3 North America Androgen Deprivation Therapy (ADT) Market Size by Type (2016-2027) 6.3 North America Androgen Deprivation Therapy (ADT) Market Size by Application 6.3.1 North America Androgen Deprivation Therapy (ADT) Market Size by Application (2016-2021) 6.3.2 North America Androgen Deprivation Therapy (ADT) Market Size by Application (2022-2027) 6.3.3 North America Androgen Deprivation Therapy (ADT) Market Size by Application (2016-2027) 6.4 North America Androgen Deprivation Therapy (ADT) Market Size by Country 6.4.1 North America Androgen Deprivation Therapy (ADT) Market Size by Country (2016-2021) 6.4.2 North America Androgen Deprivation Therapy (ADT) Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Androgen Deprivation Therapy (ADT) Market Size (2016-2027) 7.2 Europe Androgen Deprivation Therapy (ADT) Market Size by Type 7.2.1 Europe Androgen Deprivation Therapy (ADT) Market Size by Type (2016-2021) 7.2.2 Europe Androgen Deprivation Therapy (ADT) Market Size by Type (2022-2027) 7.2.3 Europe Androgen Deprivation Therapy (ADT) Market Size by Type (2016-2027) 7.3 Europe Androgen Deprivation Therapy (ADT) Market Size by Application 7.3.1 Europe Androgen Deprivation Therapy (ADT) Market Size by Application (2016-2021) 7.3.2 Europe Androgen Deprivation Therapy (ADT) Market Size by Application (2022-2027) 7.3.3 Europe Androgen Deprivation Therapy (ADT) Market Size by Application (2016-2027) 7.4 Europe Androgen Deprivation Therapy (ADT) Market Size by Country 7.4.1 Europe Androgen Deprivation Therapy (ADT) Market Size by Country (2016-2021) 7.4.2 Europe Androgen Deprivation Therapy (ADT) Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size (2016-2027) 8.2 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Type 8.2.1 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Type (2016-2027) 8.3 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Application 8.3.1 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Application (2016-2027) 8.4 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Region 8.4.1 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Androgen Deprivation Therapy (ADT) Market Size (2016-2027) 9.2 Latin America Androgen Deprivation Therapy (ADT) Market Size by Type 9.2.1 Latin America Androgen Deprivation Therapy (ADT) Market Size by Type (2016-2021) 9.2.2 Latin America Androgen Deprivation Therapy (ADT) Market Size by Type (2022-2027) 9.2.3 Latin America Androgen Deprivation Therapy (ADT) Market Size by Type (2016-2027) 9.3 Latin America Androgen Deprivation Therapy (ADT) Market Size by Application 9.3.1 Latin America Androgen Deprivation Therapy (ADT) Market Size by Application (2016-2021) 9.3.2 Latin America Androgen Deprivation Therapy (ADT) Market Size by Application (2022-2027) 9.3.3 Latin America Androgen Deprivation Therapy (ADT) Market Size by Application (2016-2027) 9.4 Latin America Androgen Deprivation Therapy (ADT) Market Size by Country 9.4.1 Latin America Androgen Deprivation Therapy (ADT) Market Size by Country (2016-2021) 9.4.2 Latin America Androgen Deprivation Therapy (ADT) Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size (2016-2027) 10.2 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Type 10.2.1 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Type (2016-2027) 10.3 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Application 10.3.1 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Application (2016-2027) 10.4 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Country 10.4.1 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Pfizer 11.1.1 Pfizer Company Details 11.1.2 Pfizer Business Overview 11.1.3 Pfizer Androgen Deprivation Therapy (ADT) Introduction 11.1.4 Pfizer Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021) 11.1.5 Pfizer Recent Development 11.2 Astellas Pharma 11.2.1 Astellas Pharma Company Details 11.2.2 Astellas Pharma Business Overview 11.2.3 Astellas Pharma Androgen Deprivation Therapy (ADT) Introduction 11.2.4 Astellas Pharma Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021) 11.2.5 Astellas Pharma Recent Development 11.3 Johnson & Johnson 11.3.1 Johnson & Johnson Company Details 11.3.2 Johnson & Johnson Business Overview 11.3.3 Johnson & Johnson Androgen Deprivation Therapy (ADT) Introduction 11.3.4 Johnson & Johnson Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021) 11.3.5 Johnson & Johnson Recent Development 11.4 Novartis International 11.4.1 Novartis International Company Details 11.4.2 Novartis International Business Overview 11.4.3 Novartis International Androgen Deprivation Therapy (ADT) Introduction 11.4.4 Novartis International Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021) 11.4.5 Novartis International Recent Development 11.5 Merck 11.5.1 Merck Company Details 11.5.2 Merck Business Overview 11.5.3 Merck Androgen Deprivation Therapy (ADT) Introduction 11.5.4 Merck Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021) 11.5.5 Merck Recent Development 11.6 Veru 11.6.1 Veru Company Details 11.6.2 Veru Business Overview 11.6.3 Veru Androgen Deprivation Therapy (ADT) Introduction 11.6.4 Veru Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021) 11.6.5 Veru Recent Development 11.7 Sanofi 11.7.1 Sanofi Company Details 11.7.2 Sanofi Business Overview 11.7.3 Sanofi Androgen Deprivation Therapy (ADT) Introduction 11.7.4 Sanofi Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021) 11.7.5 Sanofi Recent Development 11.8 GlaxoSmithKline 11.8.1 GlaxoSmithKline Company Details 11.8.2 GlaxoSmithKline Business Overview 11.8.3 GlaxoSmithKline Androgen Deprivation Therapy (ADT) Introduction 11.8.4 GlaxoSmithKline Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021) 11.8.5 GlaxoSmithKline Recent Development 11.9 Bayer 11.9.1 Bayer Company Details 11.9.2 Bayer Business Overview 11.9.3 Bayer Androgen Deprivation Therapy (ADT) Introduction 11.9.4 Bayer Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021) 11.9.5 Bayer Recent Development 11.10 Orion 11.10.1 Orion Company Details 11.10.2 Orion Business Overview 11.10.3 Orion Androgen Deprivation Therapy (ADT) Introduction 11.10.4 Orion Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021) 11.10.5 Orion Recent Development 11.11 AstraZeneca 11.11.1 AstraZeneca Company Details 11.11.2 AstraZeneca Business Overview 11.11.3 AstraZeneca Androgen Deprivation Therapy (ADT) Introduction 11.11.4 AstraZeneca Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021) 11.11.5 AstraZeneca Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Androgen Deprivation Therapy (ADT) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Medicine Table 3. Key Players of Surgery Table 4. Key Players of Other Table 5. Global Androgen Deprivation Therapy (ADT) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Androgen Deprivation Therapy (ADT) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Androgen Deprivation Therapy (ADT) Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global Androgen Deprivation Therapy (ADT) Market Share by Regions (2016-2021) Table 9. Global Androgen Deprivation Therapy (ADT) Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global Androgen Deprivation Therapy (ADT) Market Share by Regions (2022-2027) Table 11. Androgen Deprivation Therapy (ADT) Market Trends Table 12. Androgen Deprivation Therapy (ADT) Market Drivers Table 13. Androgen Deprivation Therapy (ADT) Market Challenges Table 14. Androgen Deprivation Therapy (ADT) Market Restraints Table 15. Global Androgen Deprivation Therapy (ADT) Revenue by Players (2016-2021) & (US$ Million) Table 16. Global Androgen Deprivation Therapy (ADT) Market Share by Players (2016-2021) Table 17. Global Top Androgen Deprivation Therapy (ADT) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Androgen Deprivation Therapy (ADT) as of 2020) Table 18. Ranking of Global Top Androgen Deprivation Therapy (ADT) Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by Androgen Deprivation Therapy (ADT) Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Androgen Deprivation Therapy (ADT) Product Solution and Service Table 22. Date of Enter into Androgen Deprivation Therapy (ADT) Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Androgen Deprivation Therapy (ADT) Market Size by Type (2016-2021) (US$ Million) Table 25. Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Type (2016-2021) Table 26. Global Androgen Deprivation Therapy (ADT) Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global Androgen Deprivation Therapy (ADT) Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Application (2016-2021) Table 30. Global Androgen Deprivation Therapy (ADT) Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America Androgen Deprivation Therapy (ADT) Market Size by Type (2016-2021) (US$ Million) Table 33. North America Androgen Deprivation Therapy (ADT) Market Size by Type (2022-2027) & (US$ Million) Table 34. North America Androgen Deprivation Therapy (ADT) Market Size by Application (2016-2021) (US$ Million) Table 35. North America Androgen Deprivation Therapy (ADT) Market Size by Application (2022-2027) & (US$ Million) Table 36. North America Androgen Deprivation Therapy (ADT) Market Size by Country (2016-2021) & (US$ Million) Table 37. North America Androgen Deprivation Therapy (ADT) Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe Androgen Deprivation Therapy (ADT) Market Size by Type (2016-2021) (US$ Million) Table 39. Europe Androgen Deprivation Therapy (ADT) Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe Androgen Deprivation Therapy (ADT) Market Size by Application (2016-2021) (US$ Million) Table 41. Europe Androgen Deprivation Therapy (ADT) Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe Androgen Deprivation Therapy (ADT) Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe Androgen Deprivation Therapy (ADT) Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America Androgen Deprivation Therapy (ADT) Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America Androgen Deprivation Therapy (ADT) Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America Androgen Deprivation Therapy (ADT) Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America Androgen Deprivation Therapy (ADT) Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America Androgen Deprivation Therapy (ADT) Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America Androgen Deprivation Therapy (ADT) Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Type (2016-2021) (US$ Million) Table 57. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Country (2022-2027) & (US$ Million) Table 62. Pfizer Company Details Table 63. Pfizer Business Overview Table 64. Pfizer Androgen Deprivation Therapy (ADT) Product Table 65. Pfizer Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021) & (US$ Million) Table 66. Pfizer Recent Development Table 67. Astellas Pharma Company Details Table 68. Astellas Pharma Business Overview Table 69. Astellas Pharma Androgen Deprivation Therapy (ADT) Product Table 70. Astellas Pharma Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021) & (US$ Million) Table 71. Astellas Pharma Recent Development Table 72. Johnson & Johnson Company Details Table 73. Johnson & Johnson Business Overview Table 74. Johnson & Johnson Androgen Deprivation Therapy (ADT) Product Table 75. Johnson & Johnson Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021) & (US$ Million) Table 76. Johnson & Johnson Recent Development Table 77. Novartis International Company Details Table 78. Novartis International Business Overview Table 79. Novartis International Androgen Deprivation Therapy (ADT) Product Table 80. Novartis International Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021) & (US$ Million) Table 81. Novartis International Recent Development Table 82. Merck Company Details Table 83. Merck Business Overview Table 84. Merck Androgen Deprivation Therapy (ADT) Product Table 85. Merck Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021) & (US$ Million) Table 86. Merck Recent Development Table 87. Veru Company Details Table 88. Veru Business Overview Table 89. Veru Androgen Deprivation Therapy (ADT) Product Table 90. Veru Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021) & (US$ Million) Table 91. Veru Recent Development Table 92. Sanofi Company Details Table 93. Sanofi Business Overview Table 94. Sanofi Androgen Deprivation Therapy (ADT) Product Table 95. Sanofi Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021) & (US$ Million) Table 96. Sanofi Recent Development Table 97. GlaxoSmithKline Company Details Table 98. GlaxoSmithKline Business Overview Table 99. GlaxoSmithKline Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021) & (US$ Million) Table 100. GlaxoSmithKline Recent Development Table 101. Bayer Company Details Table 102. Bayer Business Overview Table 103. Bayer Androgen Deprivation Therapy (ADT) Product Table 104. Bayer Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021) & (US$ Million) Table 105. Bayer Recent Development Table 106. Orion Company Details Table 107. Orion Business Overview Table 108. Orion Androgen Deprivation Therapy (ADT) Product Table 109. Orion Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021) & (US$ Million) Table 110. Orion Recent Development Table 111. AstraZeneca Company Details Table 112. AstraZeneca Business Overview Table 113. AstraZeneca Androgen Deprivation Therapy (ADT) Product Table 114. AstraZeneca Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021) & (US$ Million) Table 115. AstraZeneca Recent Development Table 116. Research Programs/Design for This Report Table 117. Key Data Information from Secondary Sources Table 118. Key Data Information from Primary Sources List of Figures Figure 1. Global Androgen Deprivation Therapy (ADT) Market Share by Type: 2020 VS 2027 Figure 2. Medicine Features Figure 3. Surgery Features Figure 4. Other Features Figure 5. Global Androgen Deprivation Therapy (ADT) Market Share by Application: 2020 VS 2027 Figure 6. Hospital Case Studies Figure 7. Clinic Case Studies Figure 8. Other Case Studies Figure 9. Androgen Deprivation Therapy (ADT) Report Years Considered Figure 10. Global Androgen Deprivation Therapy (ADT) Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 11. Global Androgen Deprivation Therapy (ADT) Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Androgen Deprivation Therapy (ADT) Market Share by Regions: 2020 VS 2027 Figure 13. Global Androgen Deprivation Therapy (ADT) Market Share by Regions (2022-2027) Figure 14. Global Androgen Deprivation Therapy (ADT) Market Share by Players in 2020 Figure 15. Global Top Androgen Deprivation Therapy (ADT) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Androgen Deprivation Therapy (ADT) as of 2020 Figure 16. The Top 10 and 5 Players Market Share by Androgen Deprivation Therapy (ADT) Revenue in 2020 Figure 17. Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Type (2016-2021) Figure 18. Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Type (2022-2027) Figure 19. North America Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 20. North America Androgen Deprivation Therapy (ADT) Market Share by Type (2016-2027) Figure 21. North America Androgen Deprivation Therapy (ADT) Market Share by Application (2016-2027) Figure 22. North America Androgen Deprivation Therapy (ADT) Market Share by Country (2016-2027) Figure 23. United States Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Canada Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Androgen Deprivation Therapy (ADT) Market Share by Type (2016-2027) Figure 27. Europe Androgen Deprivation Therapy (ADT) Market Share by Application (2016-2027) Figure 28. Europe Androgen Deprivation Therapy (ADT) Market Share by Country (2016-2027) Figure 29. Germany Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. France Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. U.K. Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Italy Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Russia Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Nordic Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Androgen Deprivation Therapy (ADT) Market Share by Type (2016-2027) Figure 37. Asia-Pacific Androgen Deprivation Therapy (ADT) Market Share by Application (2016-2027) Figure 38. Asia-Pacific Androgen Deprivation Therapy (ADT) Market Share by Region (2016-2027) Figure 39. China Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Japan Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. South Korea Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Southeast Asia Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. India Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Australia Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Androgen Deprivation Therapy (ADT) Market Share by Type (2016-2027) Figure 47. Latin America Androgen Deprivation Therapy (ADT) Market Share by Application (2016-2027) Figure 48. Latin America Androgen Deprivation Therapy (ADT) Market Share by Country (2016-2027) Figure 49. Mexico Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Brazil Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Share by Type (2016-2027) Figure 53. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Share by Application (2016-2027) Figure 54. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Share by Country (2016-2027) Figure 55. Turkey Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Saudi Arabia Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. UAE Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Pfizer Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2016-2021) Figure 59. Astellas Pharma Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2016-2021) Figure 60. Johnson & Johnson Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2016-2021) Figure 61. Novartis International Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2016-2021) Figure 62. Merck Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2016-2021) Figure 63. Veru Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2016-2021) Figure 64. Sanofi Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2016-2021) Figure 65. GlaxoSmithKline Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2016-2021) Figure 66. Bayer Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2016-2021) Figure 67. Orion Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2016-2021) Figure 68. AstraZeneca Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2016-2021) Figure 69. Bottom-up and Top-down Approaches for This Report Figure 70. Data Triangulation Figure 71. Key Executives Interviewed

Pfizer Astellas Pharma Johnson & Johnson Novartis International Merck Veru Sanofi GlaxoSmithKline Bayer Orion AstraZeneca